Cargando…

Platelets Promote Tumor Growth and Metastasis via Direct Interaction between Aggrus/Podoplanin and CLEC-2

The platelet aggregation-inducing factor Aggrus, also known as podoplanin, is frequently upregulated in several types of tumors and enhances hematogenous metastasis by interacting with and activating the platelet receptor CLEC-2. Thus, Aggrus–CLEC-2 binding could be a therapeutic molecular mechanism...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takagi, Satoshi, Sato, Shigeo, Oh-hara, Tomoko, Takami, Miho, Koike, Sumie, Mishima, Yuji, Hatake, Kiyohiko, Fujita, Naoya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3749157/ https://www.ncbi.nlm.nih.gov/pubmed/23991201 http://dx.doi.org/10.1371/journal.pone.0073609

Ejemplares similares

Expression of Aggrus/podoplanin in bladder cancer and its role in pulmonary metastasis
por: Takagi, Satoshi, et al.
Publicado: (2014)

Suppression of Aggrus/podoplanin-induced platelet aggregation and pulmonary metastasis by a single-chain antibody variable region fragment
por: Miyata, Kenichi, et al.
Publicado: (2014)

Targeting a novel domain in podoplanin for inhibiting platelet-mediated tumor metastasis
por: Sekiguchi, Takaya, et al.
Publicado: (2015)

A critical role of platelet TGF-β release in podoplanin-mediated tumour invasion and metastasis
por: Takemoto, Ai, et al.
Publicado: (2017)

Platelets promote osteosarcoma cell growth through activation of the platelet-derived growth factor receptor-Akt signaling axis
por: Takagi, Satoshi, et al.
Publicado: (2014)

Podoplanin-expressing inflammatory macrophages activate murine platelets via CLEC-2
por: Kerrigan, A M, et al.
Publicado: (2012)

Podoplanin maintains high endothelial venule integrity by interacting with platelet CLEC-2
por: Herzog, Brett H., et al.
Publicado: (2013)

Platelet CLEC2-Podoplanin Axis as a Promising Target for Oral Cancer Treatment
por: Hwang, Byeong-Oh, et al.
Publicado: (2021)

Identification of a novel platelet antagonist that binds to CLEC-2 and suppresses podoplanin-induced platelet aggregation and cancer metastasis
por: Chang, Yao-Wen, et al.
Publicado: (2015)

The podoplanin-CLEC-2 axis inhibits inflammation in sepsis
por: Rayes, Julie, et al.
Publicado: (2017)

Podoplanin and CLEC-2 levels in patients with COVID-19
por: Borba-Junior, Ivanio Teixeira, et al.
Publicado: (2023)

Targeting Podoplanin for the Treatment of Osteosarcoma
por: Takemoto, Ai, et al.
Publicado: (2022)

Platelet Adhesion to Podoplanin Under Flow is Mediated by the Receptor CLEC-2 and Stabilised by Src/Syk-Dependent Platelet Signalling
por: Navarro-Núñez, Leyre, et al.
Publicado: (2015)

Platelet-activating factor podoplanin: from discovery to drug development
por: Takemoto, Ai, et al.
Publicado: (2017)

Platelet CLEC-2 protects against lung injury via effects of its ligand podoplanin on inflammatory alveolar macrophages in the mouse
por: Lax, Siân, et al.
Publicado: (2017)

Podoplanin enhances lung cancer cell growth in vivo by inducing platelet aggregation
por: Miyata, Kenichi, et al.
Publicado: (2017)

The CLEC-2–podoplanin axis controls fibroblastic reticular cell contractility and lymph node microarchitecture
por: Astarita, Jillian L., et al.
Publicado: (2014)

Novel knock‐in mouse model for the evaluation of the therapeutic efficacy and toxicity of human podoplanin–targeting agents
por: Ukaji, Takao, et al.
Publicado: (2021)

Role of Bone Marrow-Derived Monocytes/Macrophages in the Repair of Mucosal Damage Caused by Irradiation and/or Anticancer Drugs in Colitis Model
por: Takaba, Junji, et al.
Publicado: (2010)

C-type lectin-like receptor (CLEC)-2, the ligand of podoplanin, induces morphological changes in podocytes
por: Tanaka, Keiko, et al.
Publicado: (2022)

Syk and Src Family Kinases Regulate C-type Lectin Receptor 2 (CLEC-2)-mediated Clustering of Podoplanin and Platelet Adhesion to Lymphatic Endothelial Cells
por: Pollitt, Alice Y., et al.
Publicado: (2014)

A pull-down and slot blot-based screening system for inhibitor compounds of the podoplanin-CLEC-2 interaction
por: Watanabe, Nobuo, et al.
Publicado: (2019)

Platelet CLEC‐2 and lung development
por: Suzuki‐Inoue, Katsue, et al.
Publicado: (2020)

Podoplanin promotes progression of malignant pleural mesothelioma by regulating motility and focus formation
por: Takeuchi, Shinji, et al.
Publicado: (2017)

Platelet-derived lysophosphatidic acid mediated LPAR1 activation as a therapeutic target for osteosarcoma metastasis
por: Takagi, Satoshi, et al.
Publicado: (2021)

Incorporation of podoplanin into HIV released from HEK-293T cells, but not PBMC, is required for efficient binding to the attachment factor CLEC-2
por: Chaipan, Chawaree, et al.
Publicado: (2010)

Podoplanin-Rich Stromal Networks Induce Dendritic Cell Motility via Activation of the C-type Lectin Receptor CLEC-2
por: Acton, Sophie E., et al.
Publicado: (2012)

Podoplanin regulates the migration of mesenchymal stromal cells and their interaction with platelets
por: Ward, Lewis S. C., et al.
Publicado: (2019)

Clec4A4 is a regulatory receptor for dendritic cells that impairs inflammation and T-cell immunity
por: Uto, Tomofumi, et al.
Publicado: (2016)

Kupffer cell receptor CLEC4F is important for the destruction of desialylated platelets in mice
por: Jiang, Yizhi, et al.
Publicado: (2021)

Clustering extent‐dependent differential signaling by CLEC‐2 receptors in platelets
por: Dangelmaier, Carol, et al.
Publicado: (2022)

Divalent nanobodies to platelet CLEC-2 can serve as agonists or antagonists
por: Clark, Joanne C., et al.
Publicado: (2023)

Characterization of Monoclonal Antibody LpMab-3 Recognizing Sialylated Glycopeptide of Podoplanin
por: Oki, Hiroharu, et al.
Publicado: (2015)

A safety study of newly generated anti-podoplanin-neutralizing antibody in cynomolgus monkey (Macaca fascicularis)
por: Ukaji, Takao, et al.
Publicado: (2018)

Extracellular vesicles from CLEC2-activated platelets enhance dengue virus-induced lethality via CLEC5A/TLR2
por: Sung, Pei-Shan, et al.
Publicado: (2019)

A novel approach to detect KRAS/BRAF mutation for colon cancer: Highly sensitive simultaneous detection of mutations and simple pre-treatment without DNA extraction
por: SUZUKI, SHUN-ICHI, et al.
Publicado: (2015)

Differential roles for the adapters Gads and LAT in platelet activation by GPVI and CLEC-2
por: HUGHES, C E, et al.
Publicado: (2008)

Molecular Analysis of the Interaction of the Snake Venom Rhodocytin with the Platelet Receptor CLEC-2
por: Watson, Aleksandra A., et al.
Publicado: (2011)

TULA-2 Deficiency Enhances Platelet Functional Responses to CLEC-2 Agonists
por: Kostyak, John C., et al.
Publicado: (2018)

Low-dose Btk inhibitors selectively block platelet activation by CLEC-2
por: Nicolson, Phillip L.R., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ms7jmf613p9lsc24lfmlrad76f